WSB2 degrades p53, which leads to decreased IGFBP3 expression and increased AKT Ser 473 phosphorylation, subsequently activating mTOR signaling and contributing to HCC carcinogenesis and metastasis (outlined in Fig. 8). The gene discussed is WSB2; the disease is hepatocellular carcinoma.